[Multicentric prospective, randomized study of the role of filgrastim (G-CSF) after transplant of hematopoietic progenitor cells mobilized with G-CSF in patients with cancer of the breast]

Sangre (Barc). 1997 Apr:42 Suppl 1:54-6.
[Article in Spanish]
No abstract available

Publication types

  • Clinical Trial
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Breast Neoplasms / blood
  • Breast Neoplasms / therapy*
  • Carboplatin / administration & dosage
  • Combined Modality Therapy
  • Cyclophosphamide / administration & dosage
  • Epirubicin / administration & dosage
  • Female
  • Filgrastim
  • Fluorouracil / administration & dosage
  • Granulocyte Colony-Stimulating Factor / therapeutic use*
  • Hematopoietic Stem Cell Mobilization
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Middle Aged
  • Neutropenia / blood
  • Neutropenia / chemically induced
  • Neutropenia / therapy*
  • Prospective Studies
  • Recombinant Proteins
  • Thiotepa / administration & dosage

Substances

  • Recombinant Proteins
  • Granulocyte Colony-Stimulating Factor
  • Epirubicin
  • Cyclophosphamide
  • Thiotepa
  • Carboplatin
  • Filgrastim
  • Fluorouracil

Supplementary concepts

  • FEC protocol